Article ID Journal Published Year Pages File Type
11018180 Urologic Oncology: Seminars and Original Investigations 2018 10 Pages PDF
Abstract
AKR1C3 is a novel EMT driver in PCa metastasis through activating ERK signaling.
Keywords
Related Topics
Health Sciences Medicine and Dentistry Oncology
Preview
AKR1C3, a crucial androgenic enzyme in prostate cancer, promotes epithelial-mesenchymal transition and metastasis through activating ERK signaling
Authors
, , , , , , , , , , , , ,